Description
Abiraterone acetate is approved to be used with prednisone to treat:
- Prostate cancer that has metastasized (spread to other parts of the body). It is used:
- In patients whose cancer is castrate resistant (has not responded to treatments that lower testosterone levels). This use is approved for the Zytiga brand name of abiraterone acetate.
- With methylprednisolone in patients whose cancer is castrate resistant. This use is approved for the Yonsa brand name of abiraterone acetate.
- In patients whose cancer is high-risk and castrate sensitive (has responded to treatments that lower testosterone levels). This use is approved for the Zytiga brand name of abiraterone acetate.